Astrazeneca PLC Enterprise Account Executive Salaries in Washington, DC
The average Astrazeneca PLC Enterprise Account Executive in Washington, DC earns an estimated $117,146 annually, which includes an estimated base salary of $90,103 with a $27,043 bonus. Astrazeneca PLC's Enterprise Account Executive compensation is $3,672 more than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at Astrazeneca PLC in Washington, DC can range from $52,000 - $205,000.
In Washington, DC, The Business Development Department at Astrazeneca PLC earns $10,932 more on average than the Finance Department.
Last updated a year ago.
- $90,103
- avg. base
- $27,043
- avg. bonus
Enterprise Account Executive Salaries at Astrazeneca PLC
In Washington, DC, Enterprise Account Executives earn $6,600 more than Account Executives, and $2,393 less than Account Managers.
Compensation at Astrazeneca PLC by Department
In Washington, DC, The Business Development Department averages $10,932 more than the Finance Department, and $8,928 less than the Design Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to Astrazeneca PLC reported making $115,417, while the average male Enterprise Account Executive at similar sized companies reported making $130,365.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average African American/Black Enterprise Account Executive at companies similar size to Astrazeneca PLC reported making $130,663, while the average Hispanic or Latino Enterprise Account Executive at similar sized companies reported making $107,000.
How Enterprise Account Executives at Astrazeneca PLC Rate Their Compensation
The majority of Enterprise Account Executives at Astrazeneca PLC believe they're compensated fairly. 100% of Enterprise Account Executives at Astrazeneca PLC say they receive annual bonuses, and the vast majority (74%) are satisfied with their benefits. See more compensation ratings at Astrazeneca PLC
